The growing demand for minimally invasive scar treatments opens up new avenues for the North America Scar Treatment Market

Purvaja Jadhao

posted on 10 months ago — updated on 2 seconds ago

63
views

The North America Scar Treatment Market is estimated to be valued at US$ 4,348.7 Mn or US$ 4.3 Bn in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The growing demand for minimally invasive scar treatments opens up new avenues for the North America Scar Treatment Market

Market Overview:
Scar treatment products include creams, gels, sheets, laser treatment devices, injectable, and other products that aim to improve the appearance and quality of scars. These products work by reducing inflammation, moisturizing the skin to promote collagen production, increasing cell turnover, and fading the appearance of scars over time. The market comprises both prescription scar treatments as well as numerous over-the-counter scar treatment products.

Market Dynamics:
Two key drivers contributing to the growth of the North America Scar Treatment Market Demand include the growing cosmetic consciousness and rising disposable incomes. As people are increasingly conscious about their physical appearance, they are willing to spend on scar treatment products and procedures to improve the aesthetic look of their body. Rising disposable incomes especially in the US and Canada have increased consumer spending on personal care and cosmetic products. Additionally, advancements in scar treatment technologies such as laser treatment devices are also driving the market growth. These devices offer minimally invasive procedures to reduce the size and depth of scars with minimal side effects.
Segment Analysis
The North America scar treatment market is primarily segmented into atrophic scars, hypertrophic scars and keloids. The hypertrophic scars segment dominates the market and is expected to maintain its dominance over the forecast period. This is due to high prevalence of hypertrophic scarring after surgeries and injuries. Hypertrophic scars have raised edges and are redder than the surrounding skin. They can itch or be painful.

PEST Analysis
Political: The scar treatment industry is regulated by the Food and Drug Administration (FDA) in the US. Any new scar treatment products require FDA approval for marketing. Changes in regulations can impact the demand for certain products.
Economic: The economic growth and rise in disposable income in North America has boosted healthcare expenditure including on aesthetic procedures. This growth is expected to drive the scar treatment market.
Social: The growing awareness about scar treatment options and increasing social acceptance of medical aesthetics is positively impacting the market growth. The desire for clear skin and removal of scars encourages people to opt for scar treatments.
Technological: New technologies like laser treatments, fractional laser resurfacing, microneedling and radiofrequency therapies allow for minimally invasive scar removal. Advancements reduce risks and improve treatment outcomes.

Key Takeaways
The North America scar treatment market size was valued at US$ 4,348.7 million in 2023 and is expected to reach US$ 6,112.8 million by 2030, registering a CAGR of 4.3% during the forecast period. Growing awareness combined with increasing disposable incomes are driving the growth of the market in North America.

Regional analysis:
The US dominates the scar treatment market in North America with the highest number of aesthetic procedures and high awareness about scar treatment options. According to the American Society of Plastic Surgeons, the number of scar revision procedures grew by 12% from 2020 to 2021 in the US, indicating growing demand.

Key players analysis:
Key players operating in the North America scar treatment market are ScarAway, Thrive Aesthetics MN, HRA Pharma, MARLO WHITNEY, Smith & Nephew Inc, Merz Therapeutics, Enaltus LLC, Oculus Innovative Sciences, Inc, CCA Industries, Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson Surface Treatment, Inc., Quantum Health, AVITA Medical, Revitol Corp, Scarguard labs, Lumenis Be Ltd, Cynosure, GC Aesthetics, Sientra, Inc, SkinCeuticals, Cimeosil.com, Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd.